Healthcare provider profile · identity verified

Julia Usatinsky, MD

Internal Medicine · MILWAUKEE, WI · NPI 1245347350

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	454	119
Amlodipine Besylate	Amlodipine Besylate	392	118
Losartan Potassium	Losartan Potassium	300	76
Albuterol Sulfate Hfa	Albuterol Sulfate	224	68
Pantoprazole Sodium	Pantoprazole Sodium	209	61
Carvedilol	Carvedilol	193	50
Metformin Hcl Er	Metformin Hcl	183	46
Furosemide	Furosemide	181	54
Omeprazole	Omeprazole	165	44
Fluticasone Propionate	Fluticasone Propionate	157	38
Gabapentin	Gabapentin	149	37
Lisinopril	Lisinopril	147	44
Rosuvastatin Calcium	Rosuvastatin Calcium	127	34
Hydrochlorothiazide	Hydrochlorothiazide	123	31
Clopidogrel	Clopidogrel Bisulfate	115	29
Tizanidine Hcl	Tizanidine Hcl	115	28
Metoprolol Tartrate	Metoprolol Tartrate	111	27
Metoprolol Succinate	Metoprolol Succinate	107	30
Potassium Chloride	Potassium Chloride	98	32
Metformin Hcl	Metformin Hcl	94	23
Allopurinol	Allopurinol	89	25
Eliquis	Apixaban	85	22
Levothyroxine Sodium	Levothyroxine Sodium	85	25
Trulicity	Dulaglutide	84	11
Pravastatin Sodium	Pravastatin Sodium	83	22
Mirtazapine	Mirtazapine	77	19
Sertraline Hcl	Sertraline Hcl	76	20
Hydralazine Hcl	Hydralazine Hcl	70	15
Lidocaine	Lidocaine	62	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	17
Januvia	Sitagliptin Phosphate	59	12
Zolpidem Tartrate	Zolpidem Tartrate	59	suppressed
Diclofenac Sodium	Diclofenac Sodium	54	21
Venlafaxine Hcl Er	Venlafaxine Hcl	54	suppressed
Spironolactone	Spironolactone	53	20
Ozempic	Semaglutide	51	suppressed
Tradjenta	Linagliptin	51	suppressed
Simvastatin	Simvastatin	46	14
Tamsulosin Hcl	Tamsulosin Hcl	44	15
Linzess	Linaclotide	41	suppressed
Bumetanide	Bumetanide	39	13
Meloxicam	Meloxicam	39	14
Mounjaro	Tirzepatide	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	18
Alprazolam	Alprazolam	37	suppressed
Lactulose	Lactulose	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Jardiance	Empagliflozin	33	15
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Prednisone	Prednisone	32	27
Famotidine	Famotidine	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Nystatin	Nystatin	24	13
Glimepiride	Glimepiride	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Ibuprofen	Ibuprofen	21	11
Meclizine Hcl	Meclizine Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Ammonium Lactate	Ammonium Lactate	20	suppressed
Torsemide	Torsemide	20	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	12
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Valsartan	Valsartan	18	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Verapamil Sr	Verapamil Hcl	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	13	suppressed
Alogliptin	Alogliptin Benzoate	12	suppressed
Baclofen	Baclofen	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Vemlidy	Tenofovir Alafenamide	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Invokana	Canagliflozin	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error